| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5298 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2761 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1660 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1331 | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 739 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ... Nature medicine 27 (2), 270-278, 2021 | 587 | 2021 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 331 | 2021 |
| T-cell activation is an immune correlate of risk in BCG vaccinated infants HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ... Nature communications 7 (1), 11290, 2016 | 292 | 2016 |
| Vertical T cell immunodominance and epitope entropy determine HIV-1 escape MKP Liu, N Hawkins, AJ Ritchie, VV Ganusov, V Whale, S Brackenridge, ... The Journal of clinical investigation 123 (1), 2012 | 214 | 2012 |
| Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction T Chen, C Blanc, AZ Eder, R Prados-Rosales, ACO Souza, RS Kim, ... The Journal of infectious diseases 214 (2), 300-310, 2016 | 127 | 2016 |
| The humoral immune response to BCG vaccination R Tanner, B Villarreal-Ramos, HM Vordermeier, H McShane Frontiers in immunology 10, 1317, 2019 | 116 | 2019 |
| Inhibition of Mycobacterial Growth In Vitro following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG HA Fletcher, R Tanner, RS Wallis, J Meyer, ZR Manjaly, S Harris, I Satti, ... Clinical and Vaccine Immunology 20 (11), 1683-1689, 2013 | 93 | 2013 |
| Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination SA Harris, J Meyer, I Satti, L Marsay, ID Poulton, R Tanner, AM Minassian, ... The Journal of infectious diseases 209 (8), 1259-1268, 2014 | 88 | 2014 |
| Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes V Naranbhai, HA Fletcher, R Tanner, MK O'Shea, H McShane, BP Fairfax, ... EBioMedicine 2 (11), 1619-1626, 2015 | 81 | 2015 |
| AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific TH1 response with a diverse TCR repertoire PA Swanson, M Padilla, W Hoyland, K McGlinchey, PA Fields, S Bibi, ... Science translational medicine 13 (620), eabj7211, 2021 | 74 | 2021 |
| Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK S Hayward, RM Harding, H McShane, R Tanner F1000Research 7, 2018 | 74 | 2018 |
| Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination K Hillson, SC Clemens, SA Madhi, M Voysey, AJ Pollard, AM Minassian The Lancet 398 (10312), 1683-1684, 2021 | 71 | 2021 |
| In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy R Tanner, MK O’Shea, HA Fletcher, H McShane Vaccine 34 (39), 4656-4665, 2016 | 71 | 2016 |
| Human standing and walking: comparison of the effects of stimulation of the vestibular system JF Iles, R Baderin, R Tanner, A Simon Experimental brain research 178, 151-166, 2007 | 67 | 2007 |
| Cytomegalovirus infection is a risk factor for tuberculosis disease in infants J Müller, R Tanner, M Matsumiya, MA Snowden, B Landry, I Satti, ... JCI insight 4 (23), 2019 | 66 | 2019 |
Helen McShaneThe Jenner Institute, University of OxfordVerified email at ndm.ox.ac.uk
